Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
NYU Langone Health and Deerfield Management Launch Amethyst Innovations with Up To $130 Million to Accelerate Commercialization of Biomedical Discoveries
NYU Langone Health and Deerfield Management Company, a healthcare investment firm, today announced the launch […]
Researchers Reveal Newfound DNA Repair Mechanism
A new study adds to an emerging, radically new picture of how bacterial cells continually […]
Plugging Immune Cell Leakage from Tumors Could Improve Skin Cancer Treatment
The number of specialized immune cells available for fighting skin cancer doubled when a new […]
Fluent BioSciences Launches Industry's Most Accessible, Cost-effective and Scalable Technology (PIPseq™) to Accelerate Adoption of Single-cell RNA Sequencing in Any Laboratory
Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]
Largest Clinical Study Validating A Blood-based Colorectal Screening Test Completes Enrollment
Freenome, a privately held biotech company, announced the completion of enrollment for PREEMPT CRC, the […]
Structure of a Bacterial "Drug Pump" Reveals New Way to Counter Hospital-borne Infection
By revealing the structure of a protein used by bacteria to pump out antibiotics, a […]
Researchers Discover New Model for "Global" DNA Repair
Two studies provide a radically new picture of how bacterial cells continually repair damaged sections […]
NYU Langone Health Launches Parekh Center for Interdisciplinary Neurology to Accelerate Scientific Discovery
NYU Langone Health announced today the launch of the Parekh Center for Interdisciplinary Neurology, made possible […]
Artificial Intelligence Tool Improves Accuracy of Breast Cancer Imaging
A computer program trained to see patterns among thousands of breast ultrasound images can aid […]
FDA Clears NYU Langone Genome PACT
The U.S. Food and Drug Administration (FDA) has cleared for clinical lab use a gene […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more